Zdrowie i gospodarka · 30/08/2011

FDA Clears Path for Aspirin and Pentazocine HCl Tablets

The FDA has determined that TALWIN COMPOUND tablets, containing 325mg of aspirin and 12.5mg of pentazocine HCl, were not withdrawn from sale due to safety or effectiveness concerns. This decision allows the FDA to potentially approve ANDA applications for these tablets if all regulatory requirements are met.